Ninety Nations Are Expected to be Represented At HIMSS

Among those 90 countries will be Israel, well-known for its outstanding health system, novel engineering acumen and always-on entrepreneurial engine. Israeli startups have been instrumental in developing breakthrough technologies and treatments, from telemedicine to augmented intelligence, precision medicine, and virtual and medical imaging. These innovations continuously improve health within Israel, home to Sheba Medical Center, one of Newsweek’s leading global hospital systems. They are exported globally, contributing to the country’s economy and worldwide standing as a top business development partner.

When the war broke out in early October 2023, Israeli attendees planning to attend the Las Vegas HLTH meeting either rushed home to reunite with family members or canceled plans to travel.  HIMSS24 Orlando will be the reboot after six gut-wrenching months when the Israeli Innovation Las Vegas HLTH Pavilion was largely vacated and war broke out.  These resilient innovators will travel to Orlando for their long-awaited plans to connect with the global health information community.

A Private Equity Firm that Champions its Portfolio Companies Globally

eHealth Ventures Group (eHV), an Israeli-headquartered private equity firm with some $1 billion under management, is planning a special HIMSS delegation of 10 of its portfolio companies – enterprises that range from start-ups to in-market companies rubbing shoulders with some of the world’s most prestigious biopharmaceutical and health system players. Some companies joining eHV Partner Ophir Shahaf focus on improving health system use of information and operations; some apply the practice value of AI and GenAI to functions where sufficient human capital is unavailable; others are pioneering new ways to address pressing medical conditions.  All come to Orlando to meet and exchange ideas with US-based colleagues during HIMSS.

Hear Medika Life Editor Gil Bashe’s exclusive interview with eHealth Venture Partner Ophir Shahaf on Healthcare Now Radio: LISTEN HERE.

From Information to Clinical Innovation Israeli Innovators Head to HIMSS

• Coronary artery disease (CAD) is a progressive condition that often remains asymptomatic for years, leading to delayed diagnosis and treatment. AccuLine has developed an accurate and non-invasive exam for the early detection of CAD to prevent millions of heart attacks. The user-friendly exam includes a four-minute measurement of vital signs, safely replacing traditional ergometry. This approach addresses the limitations of existing tools in terms of accuracy, invasiveness, and cost. The company has demonstrated promising clinical results with high precision and cost-effectiveness, supported by strategic partnerships with industry leaders, including Intratech, Sanolla, NovaSight, Lumenis, and Johnson & Johnson.

“In the fragmented health ecosystem, where patients may encounter barriers to accessing specialized care, the technology bridges this gap by offering a standardized and accessible diagnostic solution for CAD, ensuring equitable access to timely cardiac care regardless of geographic location or setting,” said Moshe Barel, Acculine CEO. Streamlining the diagnostic process and providing immediate results can accelerate time-to-care, enable clinicians to initiate prompt intervention, and improve patient outcomes.”

• Agamon Health is an imaging patient workflow management platform that leverages GenAI to connect providers and patients and coordinate the next steps in care management. By seamlessly coordinating interactions among radiologists, referring providers, nurse navigators, and patients, Agamon facilitates early diagnosis, enhances care quality, and boosts operational efficiency. Its platform accuracy has been honed, drawing from more than 20 million radiology reports, and has demonstrated a 55 percent increase in patient adherence and a 10-time return on investment.

“Care gaps are a common and unfortunate part of the health systems in the US because the system is siloed – from clinical and technical perspectives. In radiology, 20 percent of all radiology reports require some follow-up, and more than 60 percent of those patients don’t circle back, said Steve Linowes, Agamon HealthUS General Manager. This happens for several reasons. In many instances, referring providers aren’t connected to the health system that conducted the original radiology procedure, so there isn’t an easy way to communicate or have them order the follow-up procedure. This impacts more than 80 million patients annually and represents billions of dollars in lost revenue to health systems.”

• Insight Axis introduces a diagnostic tool designed for better management of neuropsychiatric disorders and improved psychiatric diagnosis and treatment. Led by a team of experts in electrophysiology, neuroscience, and mathematics, Insight Axis offers an AI-based platform that assesses treatment responsiveness, predicts medication compatibility, and characterizes disorders based on brain signatures. With no known biomarkers available for psychiatric disorders, Insight Axis provides clinicians with objective data from standard EEG tests integrated into its Quantum Physics and AI-based platform. This innovative system, backed by solid IP, promises to transform the approach to psychiatric care, ensuring more accurate diagnosis and personalized treatment recommendations.

• Thousands of neurosurgeries are performed globally daily. Each requires neuromonitoring coverage, and a specialized neurophysiologist oversees the surgeon to prevent potential nerve injuries. However, there is an insufficient number of these professionals to oversee each surgery, increasing nerve damage and paralysis risks for patients undergoing surgery without surveillance. Nervio created the world’s first autonomous neuromonitoring solution, reducing dependence on these high-demand professionals and potentially making neuromonitoring oversight available in every OR globally.

“Why does this matter to health systems, providers and patients?  A particular worry is post-injury post-spine surgery, a clinical concern now monitored using 30-year-old technology,” reflects Nervio CEO Ariel Weinstein, a long-standing entrepreneurial leader. “To increase physician and patient confidence, Nervio has created an expert-trained AI system that mirrors the vigilance of expert oversight. This technology reduces stress, risk and operating costs.”

• NimBio has developed an AI-based disease management platform to transform the treatment of immune-mediated inflammatory Diseases (IMIDs). With its focus on Inflammatory Bowel Diseases (IBD), NimBio is developing flare-up prevention technology through a 100% non-invasive remote inflammation management platform. This advanced technology, including a wearable sensor and AI-based predictive algorithm, predicts flare-ups before they occur, enabling intervention and treatment. NimBio collaborates with clinical and business partners, including Mayo Clinic and AMGEN, as it collaborates within the medical and therapeutic community to secure a unique place, timing, and perfect IMID treatment.

• Through automated data collection and its ultra-lightweight real-time locating system, QLOG enables hospitals to easily track equipment, medical supplies, and patients. By increasing visibility with its data automation solutions, QLOG helps healthcare organizations reduce costs, control processes, and assets, and improve safety and quality of care. The result is 45 percent better equipment utilization, 65 percent less supply loss and waste, and 90 percent improved compliance and safety. Leading health institutions are already deploying the QLOG in Israel and throughout Europe.

“QLOG looks to improve the way healthcare operates. We are proud to be making an impact, redefining the communication channels between the organization and the workforce, and defining how healthcare is managed,” said Dr. Amit Lehavi, QLOG founder and CEO, in announcing a successful funding round. “Our Healthcare Operations Platform displays remarkable financial impact and quality improvements across Israel and Europe. This has a direct positive influence on patient care by reducing nurse burnout and improved retention.”

• RespirAI Medical has designed an AI-powered wearable platform for long-term, at-home monitoring of chronic respiratory diseases. The device is based on a bio-coupling novel marker – measuring synchronization among breathing and walking, detecting COPD flare-ups before they flare out of control. Beyond COPD management, the platform offers health professionals the potential to identify additional respiratory and cardiac complications early and personalize medication management for these conditions.

“The RespirAI solution can improve clinical outcomes for health professionals managing chronic respiratory diseases,” says CEO Nimrod Bin-Nun. “By facilitating early detection of lung function changes and exacerbations, the RespirAI platform enables proactive intervention, reducing hospitalizations, alleviating symptom severity, and saving patient’s lives. The remote monitoring feature enhances patient convenience and lowers healthcare costs, minimizing the need for in-person visits,” he added.

• Chronic lower back pain (CLBP) impacts millions worldwide. Current care methods often focus on symptomatic relief or invasive procedures, overlooking the root mechanical imbalances contributing to CLBP. This fragmented approach leads to prolonged suffering, high healthcare costs, and limited access to adequate care. Symetrify addresses this gap in care by targeting the neuro-mechanical root cause of CLBP, providing efficient and non-invasive treatment that accelerates time-to-care decisions and improves patient outcomes. Software-based, Symetrify provides therapeutic effects while enhancing treatment capacity and efficiency for providers, focusing on patient engagement, follow-up, and retention.

“The workplace setting faces significant challenges with chronic lower back pain (CLBP), impacting millions. Current care methods often focus on symptomatic relief or invasive procedures, overlooking the root mechanical imbalances contributing to CLBP,” says Dana Chanan, CEO. “This approach leads to unnecessary suffering, high health costs, and reduces access to effective care. Symetrify addresses this gap by targeting the neuro-mechanical root cause of CLBP, providing non-invasive treatment to accelerate time-to-care decisions and improve outcomes.”

• Yonalink provides electronic data collection solutions (EDC) for clinical trial sponsors, hospitals, and contract research organizations, enabling the post-COVID ideal of decentralized clinical trials to become a reality. Its platform integrates data collection from patients’ medical devices, wearables and electronic health records (EHRs). It replaces manual processes to improve trial efficiency and reduce staff burnout—Yonalink pioneers EHR-to-EDC data streaming from a global network of more than 7000 medical centers. By simplifying data capture, management and transfer, Yonalink reduces the burden on clinical trial teams.

“By automating the data collection and management process and enabling remote data monitoring from any electronic health record, Yonalink makes clinical trial access available to any patient, anywhere,” reports Iddo Peleg, Yonalink CEO and Co-founder. “The system eliminates errors caused by manual data transfer, frees time for study staff to focus on more critical tasks, and provides sponsors with real-time data oversight to keep trial timelines on track.”

• The economic impact of migraine-related productivity loss is significant, with indirect costs to the US economy ranging from $22 billion to $78 billion annually due to missed workdays and diminished on-the-job efficiency.  Wizermed is developing a solution for migraine attack prediction before onset. Its AI-based platform, Migraine Predict, utilizes smartwatch technology to detect, predict, and manage migraines effectively. The platform can provide a daily “migraine forecast,” accurately predicting whether the next day will likely be migraine-free or if an attack is imminent. This reduces the anxiety and stress associated with the unpredictability of migraines, gives people a greater sense of control of their migraines, and enables earlier, proactive intervention to minimize the impact of a migraine.

“The capacity to foresee and alleviate the impact of imminent attacks holds significant potential for enhancing the well-being of migraine sufferers, who often feel their condition dominates their lives,” reinforces Wizermed Founder and CEO Guy Attar. “This solution empowers individuals with the means to reclaim control over their quality of life. Furthermore, this solution benefits employers by enhancing workplace productivity, reducing absenteeism, and fostering higher employee satisfaction. Notably, there’s potential to decrease the frequency and intensity of attacks, a critical consideration given the substantial prevalence of migraine sufferers in the population,” he adds.

While conflict prevails, many wonder how this impacts Israel’s innovation engine and access to investment.  According to the Israeli business publication The Israeli Business News – The Globes, “Israeli startups raised $500 million in January 2024, drawing from companies’ press announcements.”  The Globes estimates this figure might be even higher as many Israeli companies keep their investment news under the radar screen.

Overall, global investment in digital health, including health information, is down year-to-year from the exuberant COVID years. That trend is confirmed by Galen Growth, one of the world’s leading market intelligence firms; raising half a billion in month one of 2024, the Israeli health innovation sector shows resilience and strength.  HIMSS is an excellent opportunity to meet with these companies and others from the “Start-Up Nation,” whose ideas and intentions are to improve human health worldwide.

The post HIMSS – Global Meeting Ground for Health Info Innovators to Secure Partnerships and Advance Care appeared first on Medika Life.

The deaths of small children do not move us beyond tears and platitudes to policy action. What will? We are lost if we don’t demand a significant change in gun access policy after reading how a two-year-old wandered lost and frightened after both parents were shot and killed. After people going food shopping in Buffalo were slain. After people going to relax at a club in Colorado Springs were brutally murdered. How about the deaths at Walmart in Chesapeake, Virginia? Empathy drained. Courageous political action is tossed aside for preferred partisan politics.

Past policies passed in the bi-partisan Senate move are weak compromises.  They are face-saving actions for both major parties, not life-sparing policy moves that will reduce the death toll from gun violence. We need to make a move that will save lives, requiring a complete ban on automatic weapons. The Senate’s bipartisan gun deal includes additional mental health funding, increased school safety, more crisis intervention programs, and incentives for states to align juvenile records in the National Instant Criminal Background Check System. But automatic, high-powered velocity weapons – weapons of war – continue to be accessible.

High-Powered Weapon Purchases Are Climbing

In 1994, President Bill Clinton signed an assault-weapons ban, which resulted in the reduction of the AR-15 and similar semiautomatic rifles sales. The Ban only covered a 10-year window, in which mass shootings were down dramatically. When the assault-weapons ban expired 10 years later, gun manufacturers filled the production pipeline and sales rose. Recently – and tragically – the AR-15 has been at the scene of almost every mass shooting to hit the headlines in recent years. It’s design – the spin of the bullet – and firepower make killing as easy as pressing the trigger again and again until its 30-bullet magazine is spent.

The United States is witnessing a record year of gun violence – more than 600 mass shootings in 2022. The pressure is on lawmakers to enact meaningful reforms. But, little action is expected to curb this continued slaughter of the innocent.

Weapons of War are Designed for One Purpose – to Kill

For six years as a military paratrooper and combat medic, I carried an M-4, the preferred weapon of war for infantry entering combat.  The M-4 is a smaller, more convenient version of the M-16.  These are the weapons of war used in past mass shootings.  Some express misguided comfort that the A-15 is semi-auto only, and the M16 is fully automatic. But in combat situations, soldiers rarely fire on automatic. Few do, for every bullet counts.  Let’s stop calling these rifles “automatic.”  They are weapons created for war – weapons of war to wound and kill others.

Civilians are the Victims of this Gun-Epidemic War

We must heed the words of the onsite physician first responder in Highland Park, Dr. David Baum: 

“The people who were (killed) were blown up by that gunfire … blown up. The horrific scene of some bodies is unspeakable for the average person. I’ve never served, but those are wartime injuries. Those are what are seen in victims of war, not victims at a parade.”

Dr. Roy Guerrero, a healer of children who rushed to Uvalde Memorial Hospital after the massacre of 19 children and two teachers at Robb Elementary School in Texas, testified during a congressional hearing on gun violence:

“I chose to be a pediatrician. I chose to take care of children. “Keeping them safe from preventable diseases I can do. Keeping them safe from bacteria and brittle bones, I can do. But making sure our children are safe from guns, that’s the job of our politicians and leaders.”

The words of Drs Baum and Guerrero echo a simple truth: our politicians are too removed from the steady death toll and its horror to fulfill their responsibilities in protecting the nation. America is at war within itself. Our political leaders decline to call for a ceasefire despite rising body count.  Let’s call these weapons what they are – weapons of war. 

The AR-15-styled weapon was used in the Sandy Hook massacre, the Aurora theater massacre, the San Bernardino massacre, Marjory Stoneman Douglas High School in Parkland, FL, mass murder in Buffalo, NY, Uvalde, Texas, Highland Park, IL and the most recent shootings. What’s the difference between the AR-15 and its military counterpart, the M16?  They are assault weapons that hold a 30-bullet magazine and offer users the same firepower. Their killing capacity, like their power, is equal.

Congress must hold some responsibility for the murders around the nation. If its members cannot agree to protect the nation’s youngest citizens who sit in classrooms eager to learn to read, count, and play team sports, then they can either sharpen their empathy skills and feel people’s pain or consider their time in public office as a failure.

Congress Must See the Wounds of the Dead and Suffering

How can Congress show a higher degree of responsibility – a heightened connection to people’s enduring pain – physical and psychological?  Look and remember!  Each day, they should begin their sessions looking at the actual photos of those shot – the wounded and killed.  They should learn about their injuries, urgent care, and rehabilitation.  Also, each purchase of an AR-15 should require liability insurance.  Where there is no economic impact, death becomes cheap. For almost certain, once insurance companies are paying out claims, something is likely to change.

With less than 5 percent of the world’s population, the US has almost 50 percent of the world’s civilian-owned guns. The US ranks number one in firearms per capita. Our nation also has the highest homicide-by-firearm rate among the world’s most developed nations. Forget the reasons used to explain-away mass shootings; at the scene of each of these horrific acts are often weapons of war.

Americans need patriotic public service advocates in Washington, DC, who place the survival of its citizens at the forefront of their efforts.  Weapons of war, such as AR-15s, have no place in people’s home arsenals. Its bullet’s caliber rips its target apart – going in small and exiting the size of a fist. Members of Congress and their staff must be required – regardless of their political party affiliation– to see the destructive path of an AR-15 caliber bullet after every mass shooting – see the faces and hear the screams of the families impacted until those cries echo in their heads.  They must identify with the continued horror the first responders will likely experience for years.

Years after my military service, I remember the faces of the wounded and dead. I remember stemming blood from their gunshot wounds.  I hear their voices calling for distant mothers or asking if they will die. What was training and instinct – the ability to separate from the swirl around me and perform under fire – now is a movie reel that plays in my head. 

I cherish life, my role as a healer, and now, my responsibilities as a health communicator. But each moment in harm’s way was never about policy; it was about survival. Now, we are all in harm’s way wherever we go. Congress, you must transcend your political differences and imagine the cries of children murdered, calling hopelessly beforehand for their parents unable to reach out. Ban assault weapons. Ban weapons of war.

[This post was originally published on July 22nd and has now been updated to reflect the recent shootings the continued lack of Federal government action to guard its citizens’ safety.]

The post If Deaths of Small Children Do Not Move Us to Action What Will? appeared first on Medika Life.

The answer, at least the expectation of the commanding officer, was fairly simple, if not obvious. And a good ice-breaker to start the discussion. But the young pilot’s response caught his CO completely off guard. The pilot reacted, as pilots often do, with a simple and emphatic word: no.  At that moment, the tone of the conversation changed rather dramatically, and the officer looked quizzically at his inexperienced student and asked why. His answer was both factual and based on science versus speculation or military optimism. “With our current engine specifications of lift and drag, higher speeds would require the engines to be too big. And, at that size, the resulting aerodynamics would not allow a significant increase in airspeed.” Of course, the answer didn’t incorporate the jet engine which was the real game-changer and not yet available to either the military or commercial aviation.  But that innovation was just around the corner.

Years later, a young medical student was called into his attending’s office.  This time, the discussion was regarding his application for a residency program at a prestigious medical center. The conversation followed a similar path as the young pilot, as they both chatted about the evolution and transformation of medicine today and into the future.  The discussion turned from the clinical to the philosophical, as the student spoke of his father’s dissatisfaction with his current job as a primary care physician. The future seemed a bit uncertain for both father and son.

Then the question from the attending came.  “Do you feel that the physician of today, you and me, will become obsolete?”

The medical student was on guard, as this was an important interview.  So, it’s no surprise that he heard zebra hoofbeats in the distance. But still his response was swift, resolute, and almost pilot-like—he said yes. But there was more to come. He spoke eloquently of his father and how the joy of medical practice had deteriorated into a system where pre-authorization became a misplaced journey of hope for both the clinician and patient. He explained how holding a hand was replaced by holding a mouse and peering at a keyboard and screen. And he opined on how his father would come home late at night, exhausted and burned out from a system that seemed to priortize dollars over heartbeats.

His point was clear.  That physician of today is obsolete.  The role is inconsistent with the human needs and desires expressed by patients, caregivers, clinicians and all those who provide that simple four-letter word: care. But he continued about his personal expectations for tomorrow. He clearly didn’t want to become that type of physician and suffer the consequences of an oppressive system. It had little place for him or his father. 

His voice became elevated and optimistic as he presented his generation’s future and reclaiming the joy of medicine.  His vision wasn’t a compromise, but a perspective on how technology can redefine roles, share the cognitive burden, and even enhance his human capabilities such as hearing, touch, and sight. 

Just like the jet engine, advances in technology that he grew up with, can help define his humanity and redefine medical practice.  He tempered his perspective with the reality that this is no simple task or path.  And in many instances, it’s already been declared DOA by those types who still flew in the old “prop jobs” of yesterday.  He concluded with the simple observation that change, and change for the better, is at hand.  And his job, as a new intern, would certainly be to hold the hand of his patient. But sometimes, he concluded, technology might be holding his other hand.

Author’s note:  The young pilot in this story is my father, John T. Nosta who was a Naval Aviator in World War II. He later went on to become a successful electrical engineer.  His vision was both practical and forward-thinking.  And sometimes, he liked to fly very fast.  The year 2022 is the 100^th anniversary of his birth.

The post The Parable Of The Pilot And The Medical Student appeared first on Medika Life.

 How so?

The COVID pandemic has changed the way we evaluate health technologies in four important and distinct ways.

1. Practicality replaces glitz.  The “Wow factor” is what mattered in the past.  “Look how cool this laser is that can identify your heart rhythm from 300 feet away!” “This headset lets me see how food travels through my body in real time!”   Technology can still be cool, but now the question is how will I use it?  Wearables that measure important variables like blood pressure will get more attention than new imaging tools that simply provide a clearer picture.
2. Prevention takes precedence over therapeutics.  COVID has demonstrated to us the importance of our personal health.  For too long, we made our jobs and other commitments our top priority.  Going forward, one’s personal health will become a major focus, especially as it relates to prevention.  How will a particular technology let me take control of my own health?  Nowadays, I am now more interested in a toilet that can monitor my urine for signs of diabetes or my stool for colorectal cancer than a device that creates holograms.  Once one gets pass the “icky” factor of some tools,  we will evolve to truly personalized preventive medicine.
3. Rigorous outcomes rule the day.  Everything now will be measured by how did it change patient outcomes.  Sure, it a device might show a new way to measure blood glucose – but what impact does it have on quality of life, co-morbidities, and life expectancy?
4. Consumer centricity rather than physician centricity.  In the past, technology has been focused on the health system and doctors.  It’s been a B-B approach.  That won’t go away, but more and more tech innovations will put the health consumer in charge.  For instance, I won’t be wearing a device that sends all the information to my doctor, but rather there will be more interpretation of all the data from wearables with direct communication to the patient.  This may require changes in regulation by the US Food and Drug Administration with a more practical definition of what constitutes a “medical device.” 

The real future of  digital health is when tech tools  continuously collect health data points and help interpret the information and provide preliminary diagnoses to patients.   The doctor isn’t going to be left out of this equation, but the difference will be that the patient will no longer be left out.  It’s the patient who will be at the center of how these technologies function from start to finish.

I’m sure I still going to be wow-ed this year and be entertained by the advancements we have made, especially during the last two years. But I’m also going to ask tougher questions on innovation, especially as relates to the purpose and impact.

The post Four Ways COVID has Changed Health Tech appeared first on Medika Life.

Company Partners With One of World’s Largest Public HMOs, Israel’s Clalit Health Services, to Reduce Prenatal Office Visits During COVID-19 and Beyond, and Limit Trips to the ER

DATE OF RELEASE: Aug, 10, 2020

OMER, Israel /PRNewswire/ — Israeli startup PulseNmore today announced the launch of its flagship handheld tele-ultrasound device that enables pregnant women to perform at-home ultrasound scans, and receive feedback from a physician or sonographer, limiting the need for hospital and doctor visits during COVID-19 and beyond.

Clalit Health Services, Israel’s largest HMO and the one of the largest public HMOs in the world with 4.6 million insured members, is the first healthcare provider to purchase the device, signing a multi-year agreement to provide tens of thousands of its pregnant members with PulseNmore’s product.

“At home tele-ultrasound scanning is a major leap forward in digital medicine and prenatal health,” said Dr. Elazar Sonnenschein, Founder and CEO of PulseNmore. “We have successfully miniaturized the traditional ultrasound system to create a solution that is both affordable and accessible for expectant families. According to Clalit, pregnant women pay “false” visits to the emergency room more than twice on average with concerns about their baby’s well-being. Our solution provides vital information to healthcare providers to determine if a baby is healthy, helping expectant mothers have peace of mind at home and avoid unnecessary visits to the ER.” 

“We are proud to lead another breakthrough in telemedicine and to offer our members a remote and convenient ultrasound service that meets the needs of the coronavirus period and beyond,” said Professor Ehud Davidson, Director General of Clalit. “The uniqueness of our offering lies in our service concept that combines subsidizing the cost of PulseNmore’s device and offering services for medical guidance and advice provided by Clalit’s best experts.”

The PulseNmore device docks with a smartphone and utilizes advanced navigation and AI tools as well as an app to guide users through the scanning process, displaying and sharing high quality images with their healthcare professional. Physicians or sonographers review the scans remotely off-line or in real-time using telemedicine platforms and can reassure parents that all is well, or instruct them on appropriate next steps, if necessary. The device provides quick and convenient peace of mind and can potentially reduce unnecessary visits to the emergency room. In addition, the technology can be used by healthcare providers to reduce the number of prenatal office visits, which is especially useful during the current COVID-19 pandemic.

“In today’s connected world, women and their partners want and deserve to know about the well-being of their baby without having to visit the emergency room. PulseNmore makes that possible,” said Leor Wolff, Head of Translational Innovation and eHealth Division at Clalit Health Services. “Clalit’s physicians reviewed more than 1,300 self-scans in our initial study with PulseNmore and clearly saw fetal heart activity, movement and amniotic fluid in 95% of the scans. We are confident that PulseNmore’s device will support our healthcare professionals during COVID-19 and beyond, while enhancing the pregnancy experience and satisfaction for our members.”

Professor Arnon Wiznitzer, Chairman of the Department of Obstetrics and Gynecology at Rabin Medical Center will oversee the new service. He added, “Mobile medical devices enable digital information sharing with healthcare professionals for clinical consultation, follow-up, and documentation. Using these devices offers advantages in patient care and involvement, with possible benefits for clinical outcomes and cost effectiveness. Amid the COVID-19 challenges, clinicians are proposing alternative designs for prenatal care that mobilize telemedicine to allow for virtual visits as opposed to only in-person consultations.”

PulseNmore plans to build on the success of the Clalit implementation by entering key European markets in the near future. Its device is CE-Marked, has AMAR approval in Israel and is currently undergoing review by the FDA.

“Over the next year we aim to bring our technology to additional healthcare providers and countless families across the world. We are proud to pave the way for a future in which pregnant women can self-administer ultrasound scans from the comfort of home,” added Dr. Sonnenschein.

About PulseNmore

PulseNmore has developed a handheld device that allows pregnant women to perform ultrasound scans on their unborn babies from the comfort of their home. The device docks with the user’s smartphone, displays the images on the screen and sends them to a healthcare provider for analysis, helping to provide peace-of-mind and reduce unnecessary and costly emergency room visits. Founded in 2015, PulseNmore is based in Omer, Israel. For more information, please visit Pulsenmore.com.

About Clalit Health Services

Clalit is Israel’s largest health care network, provides primary, secondary and tertiary care to more than 4.6 million members (more than 52% market share). Clalit is the oldest and most experienced public general health organization in the world.

Clalit’s 14 hospitals and over 1,600 clinics and health facilities provide quality care to the special needs of patients and their families.

The combination of high-end clinical excellence and leading technological and scientific capacities makes Clalit an advanced innovation hub for promotion of basic and translational research, and for development, rapid implementation, and comprehensive assessment of new clinical insights, equipment, and practice tools.

Media Contact:
Ellie Hanson
Finn Partners
Ellie.Hanson@finnpartners.com 
+972 54-467-6980

PulseNmore Contact
Jordan Rubinson
jordan@pulsenmore.com 
+972 52-338-8744

SOURCE PulseNmore

The post At-Home Ultrasounds for Pregnant Women Now A Reality appeared first on Medika Life.